An investigation into the neuroprotective properties of ibuprofen

Metabolic Brain Disease

Volumn 15, Issue 4, 2000, Pages 249-256

  Lambat, Zaynab ^a   Conrad, Natasha ^a   Anoopkumar Dukie, Shailendra ^a   Walker, Roderick B ^a   Daya, Santy ^a  

^a RHODES UNIVERSITY   (South Africa)

Author keywords

Free radical; Ibuprofen; Neurodegeneration

Indexed keywords

CYANIDE; IBUPROFEN; MALONALDEHYDE; NEUROPROTECTIVE AGENT; NITROBLUE TETRAZOLIUM; NONSTEROID ANTIINFLAMMATORY AGENT; QUINOLINIC ACID; SUPEROXIDE; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ALZHEIMER DISEASE; ANIMAL TISSUE; BRAIN HOMOGENATE; CONFERENCE PAPER; CONTROLLED STUDY; DEGENERATIVE DISEASE; DRUG MECHANISM; LIPID PEROXIDATION; MALE; NEUROPROTECTION; NITROBLUE TETRAZOLIUM TEST; NONHUMAN; RAT;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BRAIN; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; FREE RADICALS; IBUPROFEN; LIPID PEROXIDATION; MALE; NERVE DEGENERATION; NEUROPROTECTIVE AGENTS; POTASSIUM CYANIDE; QUINOLINIC ACID; RATS; RATS, WISTAR; SUPEROXIDES;

EID: 0034446002     PISSN: 08857490     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1011115006856     Document Type: Conference Paper

References (24)

1. Agid, Y. (1991). Parkinsons disease:pathophysiology. Lancet 337:1321-1327.
2. Anoopkumar-Dukie, S., Walker, R.B., and Daya, S. A sensitive and reliable method for the detection of lipid peroxidation in biological tissues. J. Pharm. Pharmacol. (In Press).
3. 2 receptor antagonists. Neurology 54:2066-2071.
4. Ardelt, B.K., Borowitz, J.L., and Isom, G.E. (1994). Brain lipid peroxidation and antioxidant protectant mechanisms following acute cyanide intoxication. Toxicology 56:147-154.
5. Broe, G.A., Henderson, A.S., Creasey, H., McCusker, E., Korten, A.E., Jorm, A.F., Longley, W., and Anthony, J.C. ( 1990). A case-control study of Alzheimer's disease in Australia. Neurology 40:1698-1707.
6. Coyle, J., and Puttfarken P. (1993). Oxidative stress, glutamate and neurodegenerative disorders. Science 262:689-695.
7. Daya, S. (1999). The role of melatonin as a neuroprotectant in Alzheimer's disease. Spec. Med. 31:528-537.
8. Halliwell, B. (1992). Reactive oxygen species and the central nervous system. J. Neurochem. 59:1609-1623.
9. Henry, D., Lim, L.L.Y., Rodriguez, L.A.G., Gutthann, S.P., Carson, J.L., Griffin, M., Savage, R., Logan, R., Monde, Y., Hawkey, C., Hill, S. and Fries, J.T. (1996). Variability in risk of gastrointestinal complications with individual non-steroidal anti-inflammatory drugs: results of a collaborative meta-analysis. BMJ 312:1563-1566.
10. Heyes, M.P., Achim, C.L., Wiley, C.A., Major, E.O., Saito, K., and Markey, S.P. (1996). Human microglia convert L-tryptophan to the neurotoxin quinolinic acid. Biochem. J. 320:595.
11. Johnson, J.D., Conroy, W.G., Burris, K.D., and isom, G.E. (1987). Peroxidation of brain lipids following cyanide intoxication in mice. Toxicology 46:21-28.
12. Lowry, O.H., Rosebrough, N.J., Farr, A.L., and Randall, R.J.(1951). Protein measurement with the folin phenol reagent. J. Biol. Chem. 193:265-275.
13. McGeer, P.L., Akiyama, H., Itagaki, S.. and McGeer, E.G. (1989). Immune system response in Alzheimer's disease. Can. J. Neurol. Sci. 16:516-527.
14. Moroni, F., Lombard, G., Moneti, G., and Aldino, C. (1984). The excitotoxin quinolinic acid is present in the brain of several mammals and its cortical content increases during the aging process. Neurosci. Lett. 47:51.
15. Ottino, P., and Duncan, J.R. (1997). Effect of a-tocopherol succinate on free radical and lipid peroxidation levels in BL6 melanoma cells. Free Radic. Biol. Med. 22:1145-1151.
16. Rich, J.B., Rasmusson, D.X., Folstein, M.F., Carson, K.A., Kawas, C., and Brandt, J. (1995). Nonsteroidal anti-inflammatory drugs in Alzheimer's disease. Neurology 45:51-54.
17. Saano, V., Paronen, P., Peura, P., and Vidgren, M. (1991). Relative pharmacokinetics of three oral 400mg ibuprofen dosage forms in healthy volunteers. Ira. J. Clin. Pharmacol.Ther. Toxicol. 29:381-385.
18. Shaw, P.J. (1994). Excitotoxicity and motor neurone disease: a review of the evidence. J. Neurol Sci. 124:6-13.
19. Southgate, G., and Daya, S. (1999). Melatonin reduces Quinolinic acid-induced Lipid peroxidation in rat brain homogenate. Met. Brain Dis. 14:165-171.
20. Steinberg, M. (2000). Pharmacological treatment of Alzheimer's disease: an update on approved, unapproved therapies. Modern Medicine 38:47.
21. Stone, T.W. and Perkins, M.N. (1981). Quinolinic acid: A potent endogenous excitant at amino acid receptors in CNS. Eur. J. Pharmacol 72: 411-412.
22. Stone, T.W.(1993). Neuropharmacology of quinolinic acid and kynurenic acid. Pharmacol. Rev. 48:309.
23. Wolfensberger, M., Amsler, U., Cuenod, M., Foster, A.C. et al., (1983). Identification of quinolinic acid in rat and human brain tissue. Neurosci. Lett. 41:247-252.
24. Zar, J. H. (1974). Biostatistical analysis. Englewood Cliffs, NJ: Prentice Hall, 151-466.